Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease

Overview of attention for article published in Arthritis Research & Therapy, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

news: 2 news outlets

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 63 Mendeley

Summary News Dimensions citations

So far, Altmetric has seen 2 news stories from 2 outlets.

PASDAS: Targeting Multiple Aspects of PsA

Medical Health News, 10 Dec 2018

Treatment with secukinumab (Cosentyx) led to sustained remission or low disease activity using a novel, stringent outcome…

PASDAS: Targeting Multiple Aspects of PsA

MedPage Today, 10 Dec 2018

Treatment with secukinumab (Cosentyx) led to sustained remission or low disease activity using a novel, stringent outcome…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.